MOVES-eVestment names Gabriel Gilarranz VP of business development
Feb 27 Investment data and analytics firm eVestment names Gabriel Gilarranz as vice president of business development in its London office.
Dec 13 Recro Pharma Inc:
* Recro Pharma announces pricing of public offering of common stock
* Says public offering of 6.50 million common shares priced at $6.00 per share Source text for Eikon: Further company coverage:
* Biocryst reports positive interim results from its Apex-1 trial
* Interxion Holding NV - Vancis C&MS BV will continue to own and operate its existing cloud and managed services business